Literature DB >> 19807373

Epidemiology, treatment and costs of depression in adults with Type 2 diabetes.

Leonard E Egede1, Kit Simpson.   

Abstract

Worldwide, diabetes and depression are highly prevalent conditions that are independently-associated with increased healthcare costs, disability, lost productivity, and premature mortality. Approximately 10% of individuals with diabetes have major depression and 30% have both major and minor depression. Individuals with diabetes have two-fold increased odds of having depression compared with individuals without diabetes. Although, there are effective treatments for depression, studies have shown that only 50% of adults with depression are recognized in primary care and that treatment for depression is less than ideal in this setting. The epidemiology, treatment and costs of depression in adults with Type 2 diabetes are reviewed and an expert opinion on the best treatments for depression, and future clinical and research directions in this field of research are offered.

Entities:  

Year:  2003        PMID: 19807373     DOI: 10.1586/14737167.3.3.251

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  6 in total

1.  The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes.

Authors:  Leonard E Egede; Charles Ellis
Journal:  Diabetes Technol Ther       Date:  2010-04       Impact factor: 6.118

2.  Quantifying the Incremental and Aggregate Cost of Missed Workdays in Adults with Diabetes.

Authors:  Kinfe G Bishu; Mulugeta Gebregziabher; Clara E Dismuke; Leonard E Egede
Journal:  J Gen Intern Med       Date:  2015-05-19       Impact factor: 5.128

Review 3.  Multi-drug therapy in chronic condition multimorbidity: a systematic review.

Authors:  Lucy Doos; Eyitope O Roberts; Nadia Corp; Umesh T Kadam
Journal:  Fam Pract       Date:  2014-09-05       Impact factor: 2.267

4.  Prevalence and determinants of depression in type 2 diabetes patients: problem in generalization.

Authors:  Debajyoti Datta
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

5.  Detecting pre-diabetes and the role of the pharmacist.

Authors:  Steven Simoens; Sandra De Coster; Jan Lenie; Véronique Hayen; Gert Laekeman
Journal:  Pharm Pract (Granada)       Date:  2011-06-17

6.  The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation.

Authors:  Ben Kearns; R Rafia; J Leaviss; L Preston; J E Brazier; S Palmer; R Ara
Journal:  BMC Health Serv Res       Date:  2017-01-24       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.